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BACKGROUND: In developing countries, infants with Down 
syndrome and cardiac defect  are at increased risk of dying. 
Congenital heart diseases occur in 40-50% of affected infants. 
Endocardial cushion defect accounts for the most. Pattern of 
cardiac defects in Down syndrome vary  with ethnicity. The 
current study aims to determine pattern of  cardiac defects 
and survival of patients in our institution.  
METHODS: Hospital based review of cases, between April 
2010 and may  2015 were made.  Data were analyzed  using  
SPSS version 20 software quantitatively with plotted Kaplan 
Meier survival curve done. RESULTS: Down syndrome cases, 
53 male and 63 females with cardiac anomalies, were 
described.  Patent ductus arteriosus occurs in 57(36.5%), 
Ventricular septal defect in 31(19.9%), Atrial septal defect in 
30(19%), Atrio-ventricular septal defect in 
29(18.6%),Tetralogy of Fallot in 4(2.6%) and others in 
5(3.2%) cases. Cases were  alive, lost to follow-up and died in 
59, 35 and 22 cases, respectively. The overall death rate was 
19% and two-third of them died during infancy with females 
dying at an earlier age than males. Pulmonary hypertension, 
hypothyroidism and gastrointestinal disorders  were 
diagnosed in 46, 21 and 4 of the cases, respectively. Reasons 
for lost to follow-up were discussed.  
CONCLUSION: The pattern of cardiac anomalies in our 
study among Down syndrome cases is dominated by Patent 
ductus arteriosus while, the overall survival of cases is 
guarded as majority of deaths occurred during infancy 
KEYWORDS: Down syndrome, cardiovascular anomaly, 




Down syndrome (trisomy 21) is the most common chromosomal 
abnormality occurring with estimated incidence of 1.1 per 1,000 live 
births (1). The incidence of Down syndrome (DS) is increasing over 
the past few decades (2,3).Coupled with the increase in the incidence, 
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there has been a substantial increase in the life 
expectancy of cases with congenital cardiac 
defects in developed countries (4). As a matter of 
fact, following cardiac surgery, DS does not confer 
a significant mortality risk for most operations 
performed, even though post-operative morbidity 
remains common (5). 
On the other hand, in developing countries, 
infants with DS having cardiac defect  are at 
increased risk of dying in the first year of life (6). 
Although such infants require similar management 
as non-DS babies, access to treatment is a major 
challenge (2). Thus, congenital heart disease 
(CHD) is the major determinant of early mortality 
in these group of patients (7).  
In developed countries, survival to 1 year is 
now greater than  91% whereas 85% of cases can 
survive until the age of 10 years (8-10). 
Furthermore, survival studies in these countries 
showed that year of birth, gestational age at 
delivery, standardized birth weight, karyotype, and 
presence of additional structural anomalies were 
significant predictors of survival (2). 
Reports have indicated that the distribution of 
CHD in children with DS may vary  with ethnicity 
(11). As an illustration, the most common CHD 
associated with DS in the western literature is 
Atrio-ventricular septal defect followed by VSD, 
ASD, PDA and TOF (12). On the other hand, in a 
report from Koria, ASD was the most common 
defect followed by VSD, PDA, and AVSD in 
decreasing order (13). Then again, VSD was the 
commonest defect , followed by PDA, AVSD, and 
TOF in a report from Pakistan. Uniquely, the most 
common single defect  reported in the Guatemalan 
study was PDA. This  was also the most frequent 
concomitant cardiac anomaly coexisting with other 
congenital cardiac lesions (14). 
Two reports were made on the pattern of 
CHD in DS from Africa. One report from Sudan 
showed  that Common AV canal defect was the 
commonest lesion followed by VSD and TOF 
(15). This pattern was similar to the one in  the 
developed world.  The other African study which 
was from Libya  showed that  the most common 
isolated cardiac lesion reported was ASD, 
followed by AVSD  and VSD in descending order 
(16).  
Diagnosis of DS depends on the finding of 
positive karyotype for trisomy (21). However, in 
places where karyotyping is not routinely done, the 
diagnosis is made based on phenotypic features. 
Correlation of phenotypic features and karyotyping 
has been studied. As a result, accuracy of clinical 
suspicion ranges between  64% and 86% that of  
karyotyping. It was also suggested that the 
accuracy of clinical diagnosis increases when the 
assessment is made by a neonatologist or senior 
Pediatrician (17). Moreover, it was  suggested to 
use a diagnostic index like  Fried’s index, which 
may be useful in improving the accuracy of 
clinical diagnosis of DS (18) 
There is scarce data on the pattern and 
survival of children with DS having CHD in 
Ethiopia. An extrapolated data by “right diagnosis” 
estimated the number of cases of DS in Ethiopia as 
89,170 per 71,336,571 population (15,16). 
Similarly, a multi-center  hospital based study 
showed that the prevalence of DS among babies 
with birth defects is estimated to be 2% (19). 
Although in there is an assumption that cases  may 
die at an early age in Ethiopia for lack of early 
diagnosis and intervention, there is no enough 
evidence supporting this assumption. 
The current  study aims to  look into these 
pattern of  congenital cardiac anomalies and the 
factors affecting survival of cases. This will be the 
first report concerning Down syndrome in children 
from our institution. 
 
MATERIALS AND METHODS 
 
Study site: The study was conducted  at Tikur 
Anbessa Specialized Hospital (TASH) which is 
located in the center of the capital, Addis Ababa. It 
is the major tertiary and university hospital in the 
country. The pediatric cardiac clinic is one of the 
units in the Department of Pediatrics, hence run by 
pediatric cardiologists, fellows and pediatric 
residents. The Congenital Cardiac Clinic runs five 
days per week and is equipped with 
electrocardiography and echocardiographic 
machines used by pediatric cardiologists and 
fellows. Cases of DS with cardiac anomaly are 
followed both at the pediatric  cardiac and 
endocrine clinics. In the endocrine clinic cases are 
screened for hypothyroidism. The clinic  mainly 
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deals with the endocrine problems of DS cases; 
otherwise, cases are referred to other necessary 
specialties such as Eye/ENT or neurologic care 
specialists from this clinic when it is indicated. 
Study design and period: Retrospective chart  
review of cases was conducted using patient 
registry between April 2010 and  May 2015. The 
inclusion criteria includes cases fulfilling the 
definition of both phenotypes Down syndrome and 
congenital cardiac anomaly. The exclusion criteria 
applied in  cases with no echocardiographic 
confirmation of heart disease, cases with  patent 
foramen ovale, and incomplete chart.  
Sample size was calculated using  Single 
population proportion formula (Z2 *(p)*(1-p)/(e)2) 
formula,where z = 1.28( for 80% confidence 
level), P= prevalence of CHD in DS as 45%, 
e(margin of error) = 0.05, giving a sample size of 
162 cases (20). 
Study variables: Patient’s current age, sex,  
parental  address (including telephone number)  
reason for referral, referring institution, age at first 
diagnosis, history of consanguinity, maternal age 
at conception, ethnicity,  parent/gardian religion, 
family history  of congenital heart disease, types of 
cardiac lesion, pulmonary hypertension, current 
patient status (alive, died or lost to follow-up), age 
at  death, or lost to follow-up were inquired. 
Data collection procedure: Data were  collected  
from patients’ chart manually on to a structured 
questionnaire format. Log books from the clinic 
were used to get patients card number and 
identification details. Additional information was 
gathered from parents/gardians  by telephone in 
cases of  lost to follow-up. Death was confirmed 
from the hospital record and/or  from 
parents/gardians report during telephone enquiry.  
Data analysis: Data coding and manual 
proofreading were done before entering the data 
onto a computer program. Data were entered into 
SPSS software version 20. Categorical data were 
analyzed by proportions and percentiles. 
Continuous data were analyzed using mean, 
median and standard deviation. Kaplan meier 
survival curve was plotted to see the survival 
pattern. The Log Rank chi-square test was used to 
compare survival events whenever necessary. 
Statistical significance was considered with P 
value <0.05. 
Operational definitions: ‘Congenital 
cardiovascular anomalies’ refer to anatomic 
malformation of the heart or great vessels as 
confirmed by echocardiography, occurring during 
intrauterine development, irrespective of the age at 
presentation (21). ‘Current status alive’ means that 
the patient appeared on the last date of follow-up.  
On the other hand, ‘current status unknown’ means 
that the patient did not appear on the last  two or 
more days of follow-up. The patient is lost from 
follo-up, or may have a lesion which 
spontaneously closed, or he/she may have died. On 
the other hand, ‘died’ refers to death naccepted 
true when it is confirmed from hospital record  or 
when parents/guardians confirmed death during 
telephone enquiry. 
‘Phenotypic Down syndrome’ means physical 
appearance and behavior of patients with Down 
syndrome that includes, low muscle tone (babies 
appear "floppy"),  flat facial features,  small nose, 
upward slanting of the eyes, epicantal fold, small 
abnormally shaped ears, simian crease, hyper 
flexibility (excessive ability to extend joints), one 
flexion furrow instead of two on the fifth finger, 
extra space between the big toe and the second toe,  
evidence of congenital heart disease, and 
hypothyroidism. The phenotypic diagnosis of DS 
is made where there are 8 or more of the above 
Down’s features(17,22).   
‘Pulmonary hypertension (PH)’ is defined as 
pulmonary arterial pressure above 25mmHg at rest 
on echocardiographic evaluation.  The degree of 
PH was classified as mild (PAP between 25 and 
40mmHg), moderate (PAP between 41 and 
55mmHg) or severe (PAP greater than 55mmHg), 
based on the echocardiographic findings. The 
analysis of the regurgitation jet of the tricuspid 
valve was used to determine the degree of PH. The 
diagnosis of PH was established by estimating the 
peak systolic gradient of the shunt between the 
ventricles through the Bernoulli equation in 
patients with intracardiac defects (Ventricular 
septal defect). In cases with patent ductusarteriosus 
(PDA), we used the shunt between the aorta and 




We retrieved  119 phenotypic DS cases with 
congenital cardiac anomalies, of which 116 
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fulfilled the inclusion criteria and were described. 
Male-to-female ratio is 1:1.15. Mean and median 
ages at presentation were 18.6 and 9 months (IQR 
13 months), respectively. Seventy-seven (66.4%) 
cases were younger than 12 months.  
Table 1 shows the socio-demographic 
characteristics of the cases. Table 2 displays the 
pattern of congenital heart disease. Acyanotic 
congenital heart diseases accounted for 109 cases. 
The most frequent cardiac lesions in descending 
order were PDA, VSD , ASD, and AVSD. 
Multiple congenital heart diseases were seen in 39 
cases. The most frequent concomitant 
malformation co-existing with other congenital 
cardiac lesions was PDA. PDA, and AVSD were 
observed  more frequently in females while VSD 
was commonly seen in males. 
We contacted 59 cases till the end of the 
study.Thirty-five cases were lost to follow-up 
while 22 cases died.  The reasons for lost to 
follow-up were death of family members in 1 case, 
apparently improved condition in 2 cases, 
economic reasons in 2 cases, and tendency for 
another option (holy water) in 3 cases, 
respectively. In 19 cases, telephone number was 
not recorded on the chart; therefore, it was not 
possible to contact  families.   In 5 cases, the 
registered telephone number was not working. 
Mean and median ages at death were 21 and 18 
months, respectively. 
Table 1: Socio-demographic profile of cases of 
congenital cardiovascular anomalies in cases of  
Down syndrome, TASH 2018. 
 




     0-11months 
    12-59 months- 












Sex of the patient 
   Male    




























Maternal age at 
conception(yr)  
  21-35 
  36-43 















     Government 
     Private 
     Other 
















Table 2: Pattern of congenital heart disease among children born with DS, TASH 2017. 
 
Type of CHD Number Percentage 
Patent ductusarteriosus(single and combined) 57   36.5% 
Ventricular septal defect 31 19.9% 
Atrial septal defect 30     19.0 % 
Atrio-ventricular septal defect 29   18.6% 
Tetralogy of fallot                                                                 4 2.6% 
Co-arctation of Aorta                                                                                                      3 1.9% 
Pulmonary stenosis 1 0.6% 
Mitral valve prolapse 1 0.6% 
Total 156* 100% 




             Congenital Cardiovascular Anomalies…                                          Ahmed M.  et al.                       
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v29i2.3 
 
169 
The survival pattern of cases is shown in Figures 1 
and 2 by Kaplan Meier survival curve. Most deaths 
were observed during the first 48 months (Figure 
1). Females died earlier than males as seen in the 
lower survival curve (Figure 2). 
 
Figure 1: Kaplan meier survival curve among Down syndrome cases born with congenital cardiovascular 
anomalies, TASH 2017. 
	
 
Figure 2: Kaplan meier survival curve by  Gender difference,TASH 2017. 
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Pulmonary hypertension was diagnosed in 46 of 
the cases. Other associated anomalies including 
hypothyroidism and gastrointestinal disorders were 
diagnosed in 21 and 4 of the cases, respectively. 
Maternal age (mean and median) at conception 
were  32 years, with the range between  21 and 43 
years.  Sixty-nine percent of the mothers were 





The detection rate at or before one year of age for 
cardiac  anomalies in the current study  was 61%. 
This was comparable result with a similar study in 
England, which is 82%. According to reports, the 
age at which congenital cardiac anomaly is 
detected reflects the overall health facilities of a 
country (24). Most of the cases in the current study 
were diagnosed during infancy. In the first place, 
diagnosis was made  only clinically using 
phenotypic features. Since blood and ultrasound 
test were not available in Ethiopia for antenatal 
diagnosis of DS, none of the cases had confirmed 
diagnosis. Although the testes are done routinely 
on pregnant mothers in countries with well 
developed facilities, for  communities like ours, it  
is recommended to use careful clinical assessment 
of  suspected cases at birth (25) (22).  
The sex ratio of cases in the current study 
showed female preponderance. Although the 
comparison is difficult for small sample size like 
this one, the finding is in contrary to reports from 
else where. For example,Verma RS et al showed 
male predominance in their report (26). On the 
other hand, Kovaleva et al in a review of articles 
showed  a male preponderance while female 
dominance was seen  in mosaics 46/47, +21cases. 
No male preponderance was found among patients 
with DS not tested cytogenetically. They 
concluded that the female sex dominance that 
occurred may be a false-positive result (27). This 
observation may explain our finding in this study 
since none of our cases were diagnosed 
cytogenetically. Future practice should aim to do 
karyotyping for all suspected cases whenever 
possible. Likewise, higher number of females were 
found to have atrio-ventricular septal defect in the 
current study. Others also demonstrated the same 
findings (28). 
PDA is the commonest cardiac anomaly 
observed in the current study. In like manner, A 
similar  finding was reported from Guatemala (14). 
Infact, both studies were institutional.   On the 
other hand, in a population based study, from  the 
developed countries, AVSD were  reported as the 
commonest cardiac lesion among Down patients 
(29).  
Increased prevalence of PDA and ASD is 
reported with higher altitude (30). Because 
majority of our cases came from an area  where the 
altitude is above 2300 meters above sea level, our 
finding  may have some thing to do with this 
altitude difference. The mechanism of increased 
PDA at high altitude is presumed to be a 
mechanical factor affecting the pulmonary 
circulation and the lower oxygen tension that 
influence persistence of the ductus at high altitude 
(31).  
From literature point of view, we observed 
four different patterns of  cardiac lesions in DS. As 
we discussed earlier, in the reports from 
Guatamala and Nigeria, PDA was predominantly 
reported (18,28) while VSDs were reported more 
frequently  in India, China, and Saudi Arabia (5). 
It should be noted that most of these studies are 
institution based. On the other hand, AVSD is the 
most common cardiovascular anomaly observed in 
Italy and USA(12,29). The fourth pattern of 
occurrence is reported from Mexico and Libya 
showing  high proportion of ASD (32-34). 
Weather the observed differences are due to design 
effect or true ethnic difference needs to be worked 
out. Diogenes et al attributed such a difference to 
the inherent characteristics of the studied 
population (28).  
We observed high death and lost to follow-up 
rate in the current study, and most (2/3rd) of them 
occurred during infancy.Those deaths may be due 
to the frequent heart failure and/or infections.  It is 
notably reported that congenital heart disease and 
pneumonia caused frequent death  in DS babies, 
especially in early childhood (35). 
Pulmonary hypertension (PH) is observed in 
40% of the cases in the current study. 
Interestingly, patients  with DS develop pulmonary 
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hypertension  precociously leading to progressive 
right ventricular dysfunction that may kill the 
patient (36). The increased incidence of PH is 
believed to be a result of  additional problems, 
such as upper airway obstruction, pulmonary 
hypoplasia, structural lung disease, thinner media 
of the pulmonary arterioles, abnormal pulmonary 
vascular growth, alveolar hypoventilation, and 
recurrent pulmonary infection or gastro-
esophageal reflux (37). 
Ethnic, socioeconomic or geographic 
differences may also be responsible for differences 
in  mortality (38). According to reports from low 
income countries, the risks of mortality during 
infancy is double in DS cases compared to  non-
DS cases (2,35). Most deaths occurred commonly 
among girls in the current study (Figures 1 and 2). 
The reason is not clear except that we know 
congenital cardiac anomaly  occur more 
commonly in the female sex particularly AVSD, 
and the main cause of death is CHD(28). Esteban 
E, et al reported that girls died from a broader 
range of causes compared to boys (40). At the 
same time, Rankin reported that infant's gender did 
not influence survival in DS (39). Further research 
is required with larger sample size to verify these 
contradicting observations.  
In many developed countries, survival of 
cases increased markedly compared to the 
previous decades (41,42). According to reports, 
survival was increased from 77.5% in 1985–1990 
to a predicted 90.7% in 1997–2003(39). As a 
matter of fact,  people with DS typically live to 
about 55 years or longer in the US(43). 
Unfortunately, survival comparison with 
developing countries was not possible for lack of 
data in adult cases. About 41% reduction in infant 
death was reported by CDC (44). On the other 
hand, evidences on the factors affecting survival 
indicated that black maternal race, low birth 
weight, preterm birth, lower paternal education, 
presence of heart defects, and presence of other 
major congenital anomalies were important 
prognostic factors (45).  Unfortunately, the above 
problems are common in low income countries 
including Ethiopia.  
In the current study, nearly two-third of  the 
mothers were under the age of 35 years. This is 
contrary to previous reports where older mothers 
are at  risk for having affected child (46). Be that 
as it may, it was suggested that affected children 
are born to women under the age of 35 years with 
higher fertility rates than in women above the age 
of 35 years with less fertility, a feature commonly 
seen in developing countries (47,48).  
An important limitation in the current study is 
the small number of cases compared to the 
required sample size which the result may affect 
the confidence on which the conclusion is made. 
Future study with large sample size is 
recommended in order to verify our finding. 
The authors would also like to acknowledge 
problems related to the operational definition of 
phenotype features in this study, as DS like 
features can occur in some cytogenetically normal 
babies. Few studies done on the accuracy of 
clinical diagnosis showed that clinical diagnosis of 
DS is inaccurate in one-third of cases (17). On the 
other hand,  studies showed that  90%, 100% and 
37.5% of trisomy, translocation and mosaic DS, 
were diagnosed on the basis of clinical features, 
respectively (22). Therefore, our report should be 
interpreted in the light of this fact. We also like to 
acknowledge pulmonary hypertension is diagnosed 
clinically and by echocardiography only while it 
should be confirmed by cardiac catheterization. 
Moreover, specific causes of death was not 
reported and factors affecting survival in affected 
children like birth weight were not retrieved. 
Future study on the topic should address the 
limitations discussed in this study. 
In conclusion, patent ductus arteriosus is the 
commonest congenital  cardiac anomaly in 
children born with Down syndrome at our 
institution. Effort has to be made to do 
Karyotyping in all suspected cases.  Children born 
with Down syndrome should be evaluated early for 
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